Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Stomach Neoplasms 3Uterine Cervical Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Adenocarcinoma Of Esophagus 2Urothelial Bladder Carcinoma 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Solid Tumors 1Solid Tumor 1Sarcoma 1Recurrence 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasm Metastasis 1Melanoma 1Lung Neoplasms 1Liver Neoplasms 1Liposarcoma 1Glioblastoma 1Esophageal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Advanced Non-Small Cell Lung Cancer 1

Interventions

Radiotherapy 3Radiation 3palbociclib 2Magnetic Resonance Spectroscopy 2Immunoglobulin G 2Doxorubicin 2zimberelimab 1talimogene laherparepvec 1sotigalimab 1ribociclib 1pazopanib 1eribulin 1enzalutamide 1durvalumab 1cemiplimab 1abemaciclib 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Nivolumab 1Midazolam 1Letrozole 1Ipilimumab 1Ifosfamide 1Fulvestrant 1Everolimus 1Disulfides 1CTLA-4 Antigen 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Liposarcoma × zimberelimab × Clear all
NCT05886634 2025-10-20

A Study of Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
16 enrolled
Sarcoma

Liposarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡